Specialized Compliance and Safety Consulting
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves providing specialized compliance and safety consulting services focused on supporting the use of Select Agents, ensuring adherence to human subjects research protocols under the Institutional Review Board (IRB), maintaining proper animal care standards through the Institutional Animal Care and Use Committee (IACUC), and managing export control compliance. The work falls under NAICS code 541690, indicating professional scientific and technical consulting services, and is structured as a subcontract. The contract is issued by the Department of Health and Human Services, specifically through the Barda - Aspr / Daappo / Barda Dcma office, reflecting its connection to public health and advanced research initiatives. The solicitation was posted in March 2026, with a response deadline set for September 2028, signaling a long-term project timeline. While specific geographic details and points of contact are not provided, the focus on compliance across several critical regulatory areas highlights the importance of expert advisory support to maintain legal and ethical standards in research and safety operations.
General Info
Place of Performance
DC, USASet-Aside
Documents
This scope was carved out of BAA-23-100-SOL-00004.
The full solicitation package (16 documents), including the RFP, is on the prime solicitation, not on this scope.
Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Read the full solicitation package
This scope is part of a larger contract. Its documents live on the prime.
- 16 documents on the prime contractFrom Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
